Document ID: chunk:federal_register_of_legislation:F2024L01521:clause:1_23
Version: federal_register_of_legislation:F2024L01521
Segment Type: clause
Provision Reference: sch 1 cl 23
Character Range: 13279–14828

23  Schedule 1 (table)
After:
Milk protein and fat formula with vitamins and minerals -- carbohydrate free  Oral powder 225 g (Carbohydrate Free Mixture)  Oral  Carbohydrate Free Mixture  6 months stock by reference to usual PBS demand

insert:
Mirtazapine  Tablet 45 mg  Oral  NOUMED MIRTAZAPINE  between 1 December 2024 and 31 January 2025—0 months stock by reference to usual demand

24 Schedule 1 (table)
After:
Modafinil  Tablet 100 mg  Oral  Modafin  3 months stock by reference to usual demand

insert:
Modafinil          Tablet 100 mg                                   Oral  Modafinil Viatris     after 28 February 2025— 4 months stock by reference to usual demand of both Modafinil Viatris and Modafinil Mylan added together
Montelukast        Tablet, chewable, 4 mg (as sodium)              Oral  APX-Montelukast       4 months stock by reference to usual demand of both Montelukast APOTEX and APX-Montelukast added together
Montelukast        Tablet, chewable, 5 mg (as sodium)              Oral  APX-Montelukast       4 months stock by reference to usual demand of both Montelukast APOTEX and APX-Montelukast added together
Mycophenolic acid  Tablet containing mycophenolate mofetil 500 mg  Oral  ARX-MYCOPHENOLATE     4 months stock by reference to usual demand of both Mycophenolate APOTEX and ARX-MYCOPHENOLATE added together
Mycophenolic acid  Tablet containing mycophenolate mofetil 500 mg  Oral  Mycophenolate APOTEX  4 months stock by reference to usual demand of both Mycophenolate APOTEX and ARX-MYCOPHENOLATE added together